Stavros Konstantinides: Risk-adjusted treatment of PE has indeed been the focus of our
research for more than three decades, and in the 2019 ESC Guidelines we put a lot of effort …

Objective: The primary aim of this study was to investigate the mortality and associated
factors in patients with pulmonary embolism. Methods: A retrospective analysis was …

Pulmonary embolism (PE) is the third most frequent acute cardiovascular syndrome. Annual
PE incidence and PE-related mortality rates rise exponentially with age, and consequently …

Introduction PE is common and life-threatening. Thrombolysis with 100 mg alteplase is
recommended in cardiac arrest and haemodynamic instability, 1 however best management …

This position paper provides a comprehensive guide for optimal follow-up of patients with
acute pulmonary embolism (PE), covering multiple relevant aspects of patient counselling. It …

Background: Risk stratification and the therapeutic decision process in patients with acute
pulmonary embolism (PE) are complicated by lack of clinical data from large prospective …

Clinical tools that stratify risk of acute pulmonary embolism (PE) are useful in guiding
therapeutic decision making, although may neglect pragmatic and potentially impactful …

We would like to thank H. Slabbynck and co-workers for their interest in the 2019 European
Society of Cardiology/European Respiratory Society guidelines on the diagnosis and …

Methods We conducted the literature search in MEDLINE, EMBASE, the Cochrane Register
of Controlled Trials, Web of Knowledge, and CINAHL databases, until July 20, 2014. We …

Acute pulmonary embolism (PE) is a life-threating condition with high morbidity and
mortality. While current guidelines recommend systemic thrombolysis for patients with high …